Soltis Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Sell |
4,487
-1,042
| -19% | -$812K | 0.27% | 88 |
|
|
2025
Q1 | $4.57M | Buy |
5,529
+1,524
| +38% | +$1.26M | 0.41% | 68 |
|
|
2024
Q4 | $3.09M | Buy |
4,005
+2,749
| +219% | +$2.12M | 0.29% | 96 |
|
|
2024
Q3 | $1.11M | Buy |
1,256
+121
| +11% | +$107K | 0.11% | 149 |
|
|
2024
Q2 | $1.03M | Buy |
1,135
+218
| +24% | +$197K | 0.11% | 149 |
|
|
2024
Q1 | $713K | Sell |
917
-147
| -14% | -$114K | 0.08% | 167 |
|
|
2023
Q4 | $620K | Sell |
1,064
-278
| -21% | -$162K | 0.07% | 169 |
|
|
2023
Q3 | $721K | Buy |
1,342
+279
| +26% | +$150K | 0.09% | 147 |
|
|
2023
Q2 | $498K | Buy |
1,063
+78
| +8% | +$36.6K | 0.06% | 171 |
|
|
2023
Q1 | $338K | Buy |
985
+13
| +1% | +$4.47K | 0.04% | 202 |
|
|
2022
Q4 | $356K | Buy |
972
+81
| +9% | +$29.6K | 0.05% | 190 |
|
|
2022
Q3 | $288K | Buy |
891
+149
| +20% | +$48.2K | 0.04% | 192 |
|
|
2022
Q2 | $241K | Buy |
+742
| New | +$241K | 0.04% | 209 |
|